U.S. markets closed

ShockWave Medical, Inc. (SWAV)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
99.19+2.05 (+2.11%)
At close: 1:00PM EST

ShockWave Medical, Inc.

5403 Betsy Ross Drive
Santa Clara, CA 95054
United States
510 279 4262

IndustryMedical Devices
Full Time Employees284

Key Executives

NameTitlePayExercisedYear Born
Mr. Douglas E. GodshallPres, CEO & Director1.03MN/A1965
Mr. Daniel PuckettCFO & Sec.592.29kN/A1964
Mr. Isaac ZachariasChief Commercial Officer508.65kN/A1975
Mr. Daniel HawkinsFounder and Sr. AdvisorN/AN/A1967
Mr. John M. AdamsCo-Founder and Technical AdvisorN/AN/A1947
Mr. Mike MaszyVP of OperationsN/AN/AN/A
Ms. Debbie KasterHead of Investor RelationsN/AN/AN/A
Mr. Hajime Tada J.D.Gen. Counsel & Sec.N/AN/AN/A
Mr. Rob Williamson Jr.VP of SalesN/AN/AN/A
Mr. Robert FletcherVP of MarketingN/AN/AN/A
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


ShockWave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy technology to treat calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases. The company offers M5 catheters for treating above-the-knee peripheral artery disease; C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee peripheral artery disease. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company operates in the United States, Germany, rest of Europe, and internationally. ShockWave Medical, Inc. was incorporated in 2009 and is headquartered in Santa Clara, California.

Corporate Governance

ShockWave Medical, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.